Oncotelic Therapeutics, Inc.
OTLC
Revenue
70.00k
▼-1.33M▼-95.00%
39 Months ChangeAssets
26.78M
▼-3.15M▼-10.53%
3 Months ChangeLiabilities
18.65M
▲218.72k▲1.19%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-14
Form 10-Q
ID: 0001493152-24-031995
2024-05-15
Form 10-Q
ID: 0001493152-24-019332
2024-04-29
Form 8-K
ID: 0001493152-24-016839
2024-02-02
Form 8-K
ID: 0001493152-24-004783
2023-11-14
Form 10-Q
ID: 0001493152-23-040804
2023-10-30
Form 8-K
ID: 0001493152-23-038620
2023-08-23
Form 8-K
ID: 0001493152-23-029903
2023-08-18
Form 10-Q
ID: 0001493152-23-029461
2023-07-13
Form 8-K
ID: 0001493152-23-024401
2023-05-22
Form 10-Q
ID: 0001493152-23-018430